A carregar...

Protective Effects of Li-Fei-Xiao-Yan Prescription on Lipopolysaccharide-Induced Acute Lung Injury via Inhibition of Oxidative Stress and the TLR4/NF-κB Pathway

Li-Fei-Xiao-Yan prescription (LFXY) has been clinically used in China to treat inflammatory and infectious diseases including inflammatory lung diseases. The present study was aimed at evaluating the potential therapeutic effects and potential mechanisms of LFXY in a murine model of lipopolysacchari...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Evid Based Complement Alternat Med
Main Authors: Xu, Lie-Qiang, Yu, Xiu-Ting, Gui, Shu-Hua, Xie, Jian-hui, Wang, Xiu-Fen, Su, Zu-Qing, Li, Yu-Cui, Lai, Xiao-Ping, Zhan, Janis Ya-Xian, Xie, You-Liang
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5382312/
https://ncbi.nlm.nih.gov/pubmed/28424738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1791789
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!